Cargando…
MiR-26 down-regulates TNF-α/NF-κB signalling and IL-6 expression by silencing HMGA1 and MALT1
MiR-26 has emerged as a key tumour suppressor in various cancers. Accumulating evidence supports that miR-26 regulates inflammation and tumourigenicity largely through down-regulating IL-6 production, but the underlying mechanism remains obscure. Here, combining a transcriptome-wide approach with ma...
Autores principales: | Chen, Chyi-Ying A., Chang, Jeffrey T., Ho, Yi-Fang, Shyu, Ann-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856999/ https://www.ncbi.nlm.nih.gov/pubmed/27025651 http://dx.doi.org/10.1093/nar/gkw205 |
Ejemplares similares
-
Silencing of HMGA2 reverses retardance of cell differentiation in human myeloid leukaemia
por: Tan, Li, et al.
Publicado: (2018) -
HOXA1 binds RBCK1/HOIL-1 and TRAF2 and modulates the TNF/NF-κB pathway in a transcription-independent manner
por: Taminiau, Arnaud, et al.
Publicado: (2016) -
Expression of miR-26a exhibits a negative correlation with HMGA1 and regulates cancer progression by targeting HMGA1 in lung adenocarcinoma cells
por: Sekimoto, Noboru, et al.
Publicado: (2017) -
miR-26a suppresses osteosarcoma migration and invasion by directly targeting HMGA1
por: Liu, Jianyong, et al.
Publicado: (2018) -
Cross-linking of DNA through HMGA1 suggests a DNA scaffold
por: Vogel, Benjamin, et al.
Publicado: (2011)